Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.73 | 1.67 |
NAV | ₹86.55 | ₹217.21 |
Fund Started | 15 Apr 2009 | 20 Aug 2004 |
Fund Size | ₹10201.40 Cr | ₹15109.01 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year | Exit load of 1% if redeemed within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 47.39% | 43.06% |
3 Year | 19.91% | 23.65% |
5 Year | 24.02% | 22.64% |
1 Year
3 Year
5 Year
Equity | 96.26% | 86.51% |
Cash | 2.21% | 13.15% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.65% |
Sun Pharmaceutical Industries Ltd. | 6.55% |
Axis Bank Ltd. | 5.70% |
HDFC Bank Ltd. | 5.65% |
Info Edge (India) Ltd. | 3.84% |
Larsen & Toubro Ltd. | 3.82% |
Avenue Supermarts Ltd. | 3.57% |
Infosys Ltd. | 3.49% |
NTPC Ltd. | 3.48% |
Bharti Airtel Ltd. | 3.46% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.40% |
ICICI Bank Ltd. | 9.27% |
Axis Bank Ltd. | 8.56% |
HCL Technologies Ltd. | 4.76% |
SBI Life Insurance Company Ltd. | 4.39% |
Cipla Ltd. | 4.38% |
Maruti Suzuki India Ltd. | 4.38% |
Kotak Mahindra Bank Ltd. | 4.05% |
Bharti Airtel Ltd. | 3.96% |
Piramal Pharma Ltd. | 3.18% |
Name | Vaibhav Dusad | Dhruv Muchhal |
Start Date | 02 May 2020 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap. | The scheme seeks to generate long term capital appreciation/income by investing in equity & equity related instruments of up to 30 companies. |
Launch Date | 15 Apr 2009 | 20 Aug 2004 |
Description
Launch Date